ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,306Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 1844

$1.23M Total Retail Price of All Prescriptions

Rank: 24 out of 1844

740 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 740 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 740 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,319 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 841 366 1 4
HYDROCODONE-ACETAMINOPHEN 817 313 S3 2 2
LEVOTHYROXINE SODIUM 755 392 3 1
OMEPRAZOLE 748 234 4 5
PRAVASTATIN SODIUM 660 326 5 10
SIMVASTATIN 452 221 6 3
CRESTOR 348 103 7 30
MELOXICAM 345 164 8 28
METFORMIN HCL 335 158 9 8
FUROSEMIDE 332 143 10 7
CARVEDILOL 314 141 11 22
GABAPENTIN 309 75 12 15
TRAMADOL HCL 294 91 13 18
HYDROCHLOROTHIAZIDE 293 156 14 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 293 129 14 20
AMLODIPINE BESYLATE 292 158 16 6
SPIRIVA 284 89 17 57
RANITIDINE HCL 275 112 18 38
METFORMIN HCL ER 272 94 19 46
PANTOPRAZOLE SODIUM 211 65 20 32
TRAZODONE HCL 211 46 20 43
ATORVASTATIN CALCIUM 210 109 22 12
CYMBALTA 209 24 23 36
SERTRALINE HCL 195 85 24 21
ZOLPIDEM TARTRATE 195 84 24 23
METOPROLOL SUCCINATE 176 113 26 14
ADVAIR DISKUS 166 64 27 51
AMITRIPTYLINE HCL 163 46 R 28 72
POTASSIUM CHLORIDE 159 71 29 16
NEXIUM 155 55 30 31
CYCLOBENZAPRINE HCL 153 28 R 31 53
METOPROLOL TARTRATE 150 83 32 11
CITALOPRAM HBR 149 51 33 19
FLUTICASONE PROPIONATE 148 49 34 50
FLUOXETINE HCL 148 50 34 41
GLIMEPIRIDE 141 71 36 35
TRICOR 139 46 37 109
LOSARTAN POTASSIUM 138 93 38 24
OXYBUTYNIN CHLORIDE 134 85 39 103
WARFARIN SODIUM 131 48 40 13
CLOPIDOGREL 123 66 41 34
COMBIVENT 118 31 42 131
ATENOLOL 116 84 43 17
PROAIR HFA 116 28 43 45
ALENDRONATE SODIUM 112 100 45 25
CLONIDINE HCL 110 48 46 64
SPIRONOLACTONE 110 45 46 60
ROPINIROLE HCL 110 47 46 76
TIZANIDINE HCL 108 0 49 141
VENTOLIN HFA 108 25 49 145
POLYETHYLENE GLYCOL 3350 107 46 51 39
NAPROXEN 101 28 52 87
ZETIA 100 77 53 81
TOPIRAMATE 98 23 54 165
JANUVIA 97 37 55 77
ALLOPURINOL 96 53 56 29
DEXILANT 95 14 57 228
SINGULAIR 93 26 58 102
KLOR-CON M20 92 20 59 54
PLAVIX 88 46 60 61
ABILIFY 86 0 61 150
LOSARTAN-HYDROCHLOROTHIAZIDE 86 53 61 47
SYMBICORT 85 0 63 134
TRIAMTERENE-HCTZ 85 49 63 48
BUSPIRONE HCL 84 13 65 127
CIMETIDINE 82 23 66 387
ESCITALOPRAM OXALATE 77 32 67 52
ACTOS 76 67 68 130
PROMETHAZINE HCL 76 16 R 68 88
FENOFIBRATE 73 48 70 71
RAMIPRIL 72 51 71 116
ESTRADIOL 70 18 R 72 181
LACTULOSE 68 0 73 171
DICLOFENAC SODIUM 68 35 73 122
PREDNISONE 66 43 75 40
MECLIZINE HCL 64 40 76 142
SULFAMETHOXAZOLE-TRIMETHOPRIM 63 28 77 73
MONTELUKAST SODIUM 63 13 77 195
FAMOTIDINE 62 33 79 63
LEVEMIR FLEXPEN 62 20 79 166
TAMSULOSIN HCL 62 18 79 27
HYDROXYZINE HCL 61 0 R 82 164
AZITHROMYCIN 59 26 83 37
RISPERIDONE 59 0 83 65
IBUPROFEN 59 12 83 89
EVISTA 57 39 86 95
DICYCLOMINE HCL 57 0 86 197
CIPROFLOXACIN HCL 54 23 88 62
MIRTAZAPINE 53 20 89 49
LANSOPRAZOLE 53 15 89 194
LIPITOR 53 25 89 159
LYRICA 53 0 89 92
BACLOFEN 52 0 93 119
INSULIN SYRINGE 51 28 94 111
LANTUS 51 25 94 42
VENLAFAXINE HCL ER 50 0 96 93
PAROXETINE HCL 50 24 96 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 22, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.